ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 006

Implementation of Automated Depression Screening in Patients with Lupus in a Tertiary Pediatric Rheumatology Clinic

Lauren Harper1, Alana Goldstein-Leever1, James Gallup1, Vidya Sivaraman2, Stacy Ardoin1, Kyla Driest1, Evan Mulvhihill3 and Alysha Taxter4, 1Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nemours Children's Hospital, 4Nationwide Children's Hospital, Columbus, OH

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: depression, informatics, mental health, quality of care, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, March 31, 2023

Title: Plenary Abstracts Session II

Session Type: Plenary Session

Session Time: 2:30PM-3:00PM

Background/Purpose: Patients with chronic rheumatic conditions, particularly lupus, have higher rates of depression, which significantly impacts their lives and can lead to poor medication compliance and increased disease activity. Regular mental health screening is essential to optimize the care for these patients. This study aims to evaluate an automated electronic depression screening process and its integration into routine clinical care.

Methods: Patients >12 years old with a diagnosis of lupus who were evaluated at a tertiary pediatric rheumatology clinic between 2014 and 2022 were included. Depression screening using the Patient Health Questionnaire-9 (PHQ-9) was completed by paper screenings annually, transcribed into the electronic health record (EHR), and later automated in 2022 to be completed at every visit via i-Pad tablet. Positive scores were defined as score >10, or if the patient endorsed suicidality. During the automated phase of this study, an intrusive alert was displayed for positive screens during a providers workflow. Data were extracted from the EHR and providers were surveyed about the new workflows.

Results: During the study period, 149 patients completed 529 screenings. PHQ-9 administration increased from 1 patient in 2014 to 21 in 2017; after automation, screenings increased to 225 (p < 0.01) (Figure 1). Percent positive screening increased from 0% in 2014 to 25-30% in 2018-2021 and decreased to 12% in 2022 (p < 0.01) (Figure 2). The incidence of positive screens during the study period was 20%, whereas the prevalence of positive PHQ-9 screen for a single patient was 38%. The median PHQ-9 score was 3 [0, 6], and scores decreased as screening increased (Figure 3). Ten automated alerts were triggered; 9 (90%) met with psychology or social work, 9 (90%) completed suicide risk assessment, which included the Ask Suicide-Screening Questions & the Columbia Suicide Severity Rating Scale. Providers expressed satisfaction with screening and did not have objections to intrusive alerts.

Conclusion: Results demonstrate that automated screening procedures maximize the number of patients screened for depression and minimize demand on support staff. Screening at each visit provides more opportunities to identify and treat depression. Such procedures may be emulated at parallel institutions to streamline mental health screening efforts while minimizing demands.

Supporting image 1Legend: PHQ-9 = Patient Health Questionnaire-9

Supporting image 2Legend: PHQ-9 = Patient Health Questionnaire-9

Supporting image 3Legend: PHQ-9 = Patient Health Questionnaire-9


Disclosures: L. Harper: None; A. Goldstein-Leever: None; J. Gallup: None; V. Sivaraman: None; S. Ardoin: None; K. Driest: None; E. Mulvhihill: None; A. Taxter: None.

To cite this abstract in AMA style:

Harper L, Goldstein-Leever A, Gallup J, Sivaraman V, Ardoin S, Driest K, Mulvhihill E, Taxter A. Implementation of Automated Depression Screening in Patients with Lupus in a Tertiary Pediatric Rheumatology Clinic [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/implementation-of-automated-depression-screening-in-patients-with-lupus-in-a-tertiary-pediatric-rheumatology-clinic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-of-automated-depression-screening-in-patients-with-lupus-in-a-tertiary-pediatric-rheumatology-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology